Echocardiography for Management of Cardiovascular Disease in Pregnancy

被引:0
|
作者
Ziccardi, Mary Rodriguez [1 ]
Briller, Joan E. [1 ]
机构
[1] Univ Illinois, Dept Med, Div Cardiol, 840 S Wood St Mc 715, Chicago, IL 60612 USA
基金
美国国家卫生研究院;
关键词
Cardio-obstetrics; Echocardiography; Hypertensive disorders of pregnancy; Risk stratification; Global longitudinal strain; Pregnancy-associated heart failure; VENTRICULAR DIASTOLIC FUNCTION; CONGENITAL HEART-DISEASE; APPROPRIATE USE CRITERIA; MITRAL-VALVE AREA; PERIPARTUM CARDIOMYOPATHY; HYPERTENSIVE DISORDERS; EUROPEAN ASSOCIATION; CARDIAC STRUCTURE; AMERICAN SOCIETY; WOMEN;
D O I
10.1007/s11886-024-02126-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose of ReviewCardiovascular disease (CVD) continues to be a leading contributor to maternal mortality and morbidity. Echocardiography is an essential tool for patients with suspected and known CVD to establish symptom etiology, treatment strategy, and prognosis. We summarize the current status of conventional and novel techniques for assessment of CVD during pregnancy.Recent FindingsConventional techniques are still useful for evaluation of known or suspected CVD. Advanced technology using speckle tracking continues to evolve and is increasingly applied for diagnosis of subclinical disease including hypertensive disorders of pregnancy and left ventricular (LV) dysfunction. Precise recommendations on how frequently echocardiography should be performed and for whom remain in flux. However, a recently published consensus statement and new screening tool for pregnancy assessment of patients with valvular heart disease provide additional advice on using this modality.SummaryEchocardiography remains the diagnostic modality of choice for evaluation and risk stratification in pregnancy.
引用
收藏
页码:1273 / 1283
页数:11
相关论文
共 50 条
  • [41] Medical Management of Cardiovascular Disease
    Steiger, Kyle
    Fuentes, Ana
    Erben, Young
    SURGICAL CLINICS OF NORTH AMERICA, 2023, 103 (04) : 565 - 575
  • [42] Cardiovascular Disease and Risk Management
    不详
    DIABETES CARE, 2015, 38 : S49 - S57
  • [43] Propolis in the management of cardiovascular disease
    Chavda, Vivek P.
    Vuppu, Suneetha
    Balar, Pankti C.
    Mishra, Toshika
    Bezbaruah, Rajashri
    Teli, Divya
    Sharma, Nikita
    Alom, Shahnaz
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2024, 266
  • [44] Pharmacogenomics and management of cardiovascular disease
    Howe, Linda A.
    NURSE PRACTITIONER, 2009, 34 (08): : 28 - 35
  • [45] Cardiovascular disease management in Ireland
    Shurlock, B
    CIRCULATION, 2006, 113 (20) : 77 - 78
  • [46] Gliflozins in the Management of Cardiovascular Disease
    Braunwald, Eugene
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (21): : 2024 - 2034
  • [47] Management of cardiovascular disease in haemophilia
    Cayla, Guillaume
    Morange, Pierre-Emmanuel
    Chambost, Herve
    Schved, Jean-Francois
    THROMBOSIS RESEARCH, 2013, 132 (01) : 8 - 14
  • [48] THE MANAGEMENT OF HYPERTENSIVE CARDIOVASCULAR DISEASE
    MEILMAN, E
    CIRCULATION, 1956, 13 (04) : 596 - 607
  • [49] Gliflozins in the Management of Cardiovascular Disease
    Leslie, Bruce R.
    Gerwin, Leslie E.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (05): : 478 - 478
  • [50] MANAGEMENT OF HYPERTENSIVE DISEASE OF PREGNANCY
    MARTIN, JD
    DRUGS, 1974, 8 (02) : 125 - 131